PCSK9 inhibitors (PSK9i)

PCSK9 Inhibitors

 

The PCSK9 inhibitors (PSK9i) are a newer class of injectable drugs that have been shown to dramatically lower LDL cholesterol levels, by up to 60% when combined with a statin drug

1. Repatha generic name: evolocumab 
2. Praluent generic name: alirocumab